⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5458200 | 0.82 | — | — | |
| SCHEMBL3728489 | 0.82 | — | — | |
| SCHEMBL23203046 | 0.78 | CHRNA7 (0.31) | — | |
| SCHEMBL11266183 | 0.78 | KDM1A (0.34) | — | |
| SCHEMBL734440 | 0.75 | KDM1A (0.38) | — | |
| SCHEMBL6984232 | 0.73 | — | — | |
| SCHEMBL3992251 | 0.73 | KDM1A (0.36) | — | |
| SCHEMBL365626 | 0.73 | CHRNA7 (0.32) | — | |
| SCHEMBL10418779 | 0.73 | HTR2A (0.34) | — | |
| SCHEMBL1153469 | 0.72 | KDM1A (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007117482-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | claimed |
| CN-111635415-B | Compound, electron transport material and organic electroluminescent device | 烟台显华化工科技有限公司 | 2023-07-25 | — | — | CN | disclosed |
| US-11611045-B2 | Organic compound, electronic component containing organic compound, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-03-21 | — | — | US | disclosed |
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
| CN-113937231-A | Organic electroluminescent device and electronic apparatus | 陕西莱特迈思光电材料有限公司 | 2022-01-14 | — | — | CN | disclosed |
| WO-2021129072-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2021-07-01 | — | — | WO | disclosed |
| CN-111018797-B | Organic compound, electronic element containing the same, and electronic device | 陕西莱特光电材料股份有限公司 | 2021-01-05 | — | — | CN | disclosed |
| CN-111635415-A | Compound, electron transport material and organic electroluminescent device | 烟台显华化工科技有限公司 | 2020-09-08 | — | — | CN | disclosed |
| CN-111018797-A | Organic compound, electronic element containing the same, and electronic device | 陕西莱特光电材料股份有限公司 | 2020-04-17 | — | — | CN | disclosed |
| US-8455521-B2 | Diaminoalkane aspartic protease inhibitors | VITAE PHARMACEUTICALS, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| US-20090018103-A1 | Diaminoalkane Aspartic Protease Inhibitors | VITAE PHARMACEUTICAL, INC (US) | 2009-01-15 | — | — | US | disclosed |
| EP-2010488-A2 | RENIN INHIBITORS | Vitae Pharmaceuticals, Inc. (US) | 2009-01-07 | — | — | EP | disclosed |
| WO-2008124575-A1 | RENIN INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008124582-A1 | RENIN INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008124577-A1 | RENIN INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2007117559-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007117560-A2 | PIPERIDINE AND MORPHOLINE RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007117482-A2 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-10-18 | — | — | WO | disclosed |
| EP-1807078-A1 | DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS | Vitae Pharmaceuticals, Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006042150-A1 | DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2006-04-20 | — | — | WO | disclosed |